Funding for this research was provided by:
Fondation Pierre Mercier pour la Science (x)
Stiftung Synapsis - Alzheimer Forschung Schweiz AFS (x)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030L_141179)
Received: 4 July 2019
Accepted: 30 October 2019
First Online: 28 November 2019
Ethics approval and consent to participate
: The Ethics Committee of the canton of Vaud, Switzerland, approved the study, and written informed consent was received from all participants before inclusion into the study.
: Not applicable.
: JP received consultation honoraria from Nestle Institute of Health Sciences, Innovation Campus, EPFL, Lausanne, Switzerland, Ono Pharma and from Fujirebio Europe. The other authors declare that they have no competing interests.